Hospital Clínico Universitario Lozano Blesa -ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

2015

  1. Are all new allergens in TRUE Test® essential for a baseline set?

    Contact Dermatitis

2014

  1. Management of angioedema without urticaria in the emergency department

    Annals of Medicine, Vol. 46, Núm. 8, pp. 607-618

2013

  1. Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs

    Journal of Allergy and Clinical Immunology, Vol. 132, Núm. 4, pp. 989-991

  2. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

2012

  1. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

  2. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification

    Rhinology, Vol. 50, Núm. 1, pp. 33-36

2010

  1. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 65, Núm. 12, pp. 1609-1613

2009

  1. Component-resolved diagnosis of pollen allergy based on skin testing with profilin, polcalcin and lipid transfer protein pan-allergens

    Clinical and Experimental Allergy, Vol. 39, Núm. 11, pp. 1764-1773

  2. Reference values for facilitating the interpretation of the ESPRINT-15 Questionnaire (Spanish Version)

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. 5, pp. 396-403

2007

  1. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items

    Journal of Allergy and Clinical Immunology, Vol. 120, Núm. 2, pp. 359-365

  2. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: The ESPRINT questionnaire

    Value in Health, Vol. 10, Núm. 6, pp. 466-477

  3. Health-related quality of life in allergic rhinitis: Comparing the short form ESPRINT-15 and MiniRQLQ questionnaires

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 62, Núm. 12, pp. 1372-1378

2004

  1. Anaphylaxis to boldo infusion, a herbal remedy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 59, Núm. 9, pp. 1019-1020

1998

  1. Medical personnel and patient skill in the use of metered dose inhalers: A multicentric study

    Respiration, Vol. 65, Núm. 3, pp. 195-198